RxDoctor Payments Data

Melissa Jones

Neurology with Special Qualifications in Child Neurology · Katy, TXNPI 1114170123

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 99.4% of the total across 476 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 56 manufacturers, the largest accounting for just 12.3% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2024 at $1,975 and has fallen 55.3% since, to $883 in 2025.

$9,744in general payments, 2019–2025

Across 476 payments — averaging $20.47 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • UCB, Inc.$1K
  • Supernus Pharmaceuticals, Inc.$1K
  • W. L. Gore & Associates, Inc.$725
  • Jazz Pharmaceuticals Inc.$706
  • Ironshore Pharmaceuticals Inc.$584
  • Neurelis, Inc.$508
  • plus $5K from 50 others

What the payments were for

  • Food & beverage$9,68299%
  • Education$621%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
UCB, Inc.60$1,196
Supernus Pharmaceuticals, Inc.85$1,147
W. L. Gore & Associates, Inc.7$725
Jazz Pharmaceuticals Inc.38$706
Ironshore Pharmaceuticals Inc.39$584
Neurelis, Inc.17$508
Corium, LLC22$442
Eisai Inc.19$417
Neos Therapeutics, LP29$366
Tris Pharma Inc20$363
Sunovion Pharmaceuticals Inc.3$351
Greenwich Biosciences, Inc.20$339
Aquestive Therapeutics, Inc.13$251
Harmony Biosciences LLC9$228
SK Life Science, Inc.11$226
Sumitomo Pharma America, Inc.11$209
Avadel CNS Pharmaceuticals, LLC6$159
E.r. Squibb & Sons, L.L.C.1$119
Livanova USA, Inc.4$115
AbbVie(2 entities)5$106
Arbor Pharmaceuticals, Inc.6$102
Acadia Pharmaceuticals Inc4$93
Octapharma USA, Inc.2$84
Takeda Pharmaceuticals U.S.A., Inc.3$81
Biohaven Pharmaceutical Holding Company Ltd.4$75
Shire North American Group Inc3$49
Aprecia Pharmaceuticals, LLC1$47
Biogen2$41
Catalyst Pharmaceuticals, Inc.2$41
Biohaven Pharmaceuticals, Inc.2$41
Zogenix Inc.2$34
PTC Therapeutics, Inc.1$32
Johnson & Johnson1$31
Rhodes Pharmaceuticals L.p.2$30
Otter Pharmaceuticals, LLC1$29
Immedica Pharma US, Inc.1$28
Vertical Pharmaceuticals, LLC1$26
Axsome Therapeutics, Inc.1$26
Hospira, Inc.1$25
Mallinckrodt Enterprises LLC1$25
Collegium Pharmaceutical, Inc.1$23
Novartis1$23
Pfizer1$22
Teva Pharmaceuticals USA, Inc.1$17
Noven Therapeutics, LLC1$17
Assertio Therapeutics, Inc.1$16
Ultragenyx Pharmaceutical Inc.1$15
OWP Pharmaceuticals, Inc.1$14
Upsher-smith Laboratories LLC1$14
Adlon Therapeutics L.p.1$14
Cranial Technologies, Inc1$14
Promius Pharma LLC1$14
Sanofi1$13
Aucta Pharmaceuticals, Inc.1$12
Biomarin Pharmaceutical Inc.1$11
Travere Therapeutics, Inc.1$10

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$9,744 in reported general payments places this provider in the 85th percentile of 193 neurology with special qualifications in child neurology providers in Texas.

See all neurology with special qualifications in child neurology providers in Texas

Other neurology with special qualifications in child neurology in Katy

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →